16 Mar 2023 Aitia and UCB announce strategic drug discovery collaboration in Huntington's Disease Member news
14 Mar 2023 Oxurion provides update on recruitment for KALAHARI Phase 2, Part B trial of novel PKal inhibitor THR-149 in diabetic macular edema and announces Board changes Member news
09 Mar 2023 Cancer Research UK signs multi-project collaboration with UCB to advance oncology antibody candidates Member news
06 Mar 2023 Mithra announces promising topline safety results from Donesta® Phase 3 Study in North America Member news
02 Mar 2023 VIB spin-off Flamingo Therapeutics merges with Dynacure to create leading RNA therapeutics company in oncology Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
